Discover the power of real-time signals plus AI
Every funding round, exec hire, M&A move, contract, and sentiment shift on VieCure — with verified, ICP-scored contact reveals (email + mobile) on demand.
Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.
VieCure has raised $43 million in a funding round led by Mitch Rales and Northpond Ventures to enhance cancer care access in community practices.
Amount Raised
$43 Million
Investors
Description
VieCure, a leading provider of intelligent software for oncology care, has secured $43 million to advance precision medicine in community cancer practices. The funding was led by Mitch Rales and Northpond Ventures and includes participation from Durable Capital Partners and Socium Ventures. This investment aims to alleviate the growing complexities in cancer care and enhance patient outcomes. CEO Michael Power stated that this investment is pivotal for transforming cancer care delivery.
Related People
Sign in to view contact details
Funding Insights
Based on industry dataWatching VieCure? See every signal — funding, hires, M&A, contracts, sentiment.
See plans